EUVIMEDOpdag EUVIMED
MetaanalyseSystematische Übersicht

Meta‐Analysis: Efficacy and Safety of Sequestrants for Bile Acid Diarrhoea

Saam Dilmaghani, Joelle BouSaba, Camille Lupianez-Merly, Larry Prokop, M Hassan Murad, Michael Camilleri iD

Alimentary Pharmacology & Therapeutics · 2025-12 · 62 (11-12) · 1054-1065

DOI: 10.1111/apt.70390 ↗

At a glance

Metaanalyse in Alimentary Pharmacology & Therapeutics, published online on 2025-10-15. Written by Saam Dilmaghani and 5 co-authors. Institution: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. Major MEDLINE topics: Bile Acids and Salts, Diarrhea, Irritable Bowel Syndrome, Sequestering Agents. Cited 3 times so far (Crossref); 37 references. Funded by: NIH HHS, National Institutes of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Bile acid diarrhoea, a common cause of diarrhoea‐predominant irritable bowel syndrome, has a similar prevalence to coeliac disease and inflammatory bowel diseases. The mainstay of treatment is bile acid sequestrants (BAS). The effectiveness of using bile acid‐targeted therapies remains unclear.

Aim

To compare BAS with placebo for bile acid diarrhoea.

Methods

We conducted a systematic review and meta‐analysis of randomised controlled trials comparing BAS to placebo using a comprehensive search of databases from inception to 8/1/2023. Inclusion required unequivocal diagnosis using serum or faecal biochemical parameters, or 75 SeHCAT. Co‐primary endpoints were ≥ 30% improvement in bowel movement consistency and frequency averaged over 7 days. Adverse effects were also summarised.

Results

Database search resulted in 1152 citations; 1 additional study was added. Ultimately, 6 trials (5 parallel arm, 1 crossover) involving 182 participants evaluated the effectiveness of BAS over 1–8 weeks. Participants were between the third and seventh decades of life and mostly female. The risk of bias was low except in one parallel and one crossover trial. Meta‐analysis of parallel‐design trials of sequestrants only showed a clinically significant reduction in stool consistency and frequency with pooled relative risks of 1.50 (95% CI: 1.14–1.96) and 2.80 (95% CI: 1.68–4.67), respectively. There was no observable heterogeneity ( I 2 = 0%), and the certainty of evidence was moderate. There was no statistically significant difference in adverse effects.

Conclusions

This study quantifies the significant and rapid improvement in both stool consistency and frequency with BAS in patients with objective diagnosis of bile acid diarrhoea. Sequestrants also appear well tolerated.

Subjects

MeSH terms (MEDLINE)

Bile Acids and SaltsDiarrheaIrritable Bowel SyndromeSequestering AgentsFemaleHumansMaleRandomized Controlled Trials as TopicTreatment Outcome

Substances

Bile Acids and SaltsSequestering Agents

Authors and institutions

  • Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Library Services, Mayo Clinic, Rochester, Minnesota, USA.
  • Evidence-Based Practice Center, Kern Center for the Science of Healthcare Delivery, Mayo Clinic, Rochester, Minnesota, USA.

ORCID profiles: Michael Camilleri

Funding

  • NIH HHS
  • National Institutes of Health

Cite

APA

Dilmaghani, S., BouSaba, J., Lupianez-Merly, C., Prokop, L., Murad, M. H., & Camilleri, M. (2025). Meta‐Analysis: Efficacy and Safety of Sequestrants for Bile Acid Diarrhoea. Alimentary Pharmacology & Therapeutics, 62(11-12), 1054-1065. https://doi.org/10.1111/apt.70390

Vancouver

Dilmaghani S, BouSaba J, Lupianez-Merly C, Prokop L, Murad MH, Camilleri M. Meta‐Analysis: Efficacy and Safety of Sequestrants for Bile Acid Diarrhoea. Alimentary Pharmacology & Therapeutics. 2025;62(11-12):1054-1065. doi:10.1111/apt.70390

BibTeX
@article{Dilmaghani2025,
  author = {Dilmaghani, Saam and BouSaba, Joelle and Lupianez-Merly, Camille and Prokop, Larry and Murad, M Hassan and Camilleri, Michael},
  title = {Meta‐Analysis: Efficacy and Safety of Sequestrants for Bile Acid Diarrhoea},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  volume = {62},
  number = {11-12},
  pages = {1054--1065},
  doi = {10.1111/apt.70390}
}
Start for free →